Hanmi releases simvastin CR tablets

Hanmi Pharm said on February 2 that it has launched its new simvastin controlled-release (CR) 20 mg tablets, followed by its best-selling second simvastin series.

According to the company, the advantages of once-daily simvastin CR tablets are that they can often be taken less frequently than instant-release formulations of the same drug, and that they keep steadier levels of the drug in the ...